- Home
- ONCY vs FBIO Comparison
ONCY vs FBIO Comparison
Compare ONCY & FBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONCY
- FBIO
- Stock Information
- Founded
- ONCY 1998
- FBIO 2006
- Country
- ONCY Canada
- FBIO United States
- Employees
- ONCY N/A
- FBIO N/A
- Industry
- ONCY Pharmaceuticals and Biotechnology
- FBIO Biotechnology: Pharmaceutical Preparations
- Sector
- ONCY Health Care
- FBIO Health Care
- Exchange
- ONCY Nasdaq
- FBIO Nasdaq
- Market Cap
- ONCY 49.1M
- FBIO 49.1M
- IPO Year
- ONCY 1999
- FBIO N/A
- Fundamental
- Price
- ONCY $0.92
- FBIO $1.88
- Analyst Decision
- ONCY Strong Buy
- FBIO Strong Buy
- Analyst Count
- ONCY 4
- FBIO 2
- Target Price
- ONCY $4.33
- FBIO $21.00
- AVG Volume (30 Days)
- ONCY 1.4M
- FBIO 232.4K
- Earning Date
- ONCY 07-31-2025
- FBIO 08-12-2025
- Dividend Yield
- ONCY N/A
- FBIO N/A
- EPS Growth
- ONCY N/A
- FBIO N/A
- EPS
- ONCY N/A
- FBIO N/A
- Revenue
- ONCY N/A
- FBIO $57,784,000.00
- Revenue This Year
- ONCY N/A
- FBIO $51.59
- Revenue Next Year
- ONCY N/A
- FBIO $44.74
- P/E Ratio
- ONCY N/A
- FBIO N/A
- Revenue Growth
- ONCY N/A
- FBIO N/A
- 52 Week Low
- ONCY $0.33
- FBIO $1.33
- 52 Week High
- ONCY $1.53
- FBIO $2.89
- Technical
- Relative Strength Index (RSI)
- ONCY 78.48
- FBIO 54.35
- Support Level
- ONCY $0.71
- FBIO $1.76
- Resistance Level
- ONCY $0.81
- FBIO $1.89
- Average True Range (ATR)
- ONCY 0.09
- FBIO 0.09
- MACD
- ONCY 0.02
- FBIO -0.00
- Stochastic Oscillator
- ONCY 89.43
- FBIO 79.17
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.
About FBIO Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.